Oral administration of anti-lipopolysaccharide factor isoform 3 via the bait microalga for controlling bacterial infection of Atlantic Bay scallop (Argopecten irradians)

In order to reduce antibiotic application in aquaculture, an antimicrobial peptide anti-lipopolysaccharide factor isoform 3 (ALFPm3) with highly effective inhibitory activity against pathogens was introduced to bay scallop ( Argopecten irradians ) using bait microalga Tetraselmis subcordiformis as a delivery system. To improve its expression and stability, a fusion of two alfpm3 genes ( alfpm3–2 ) was inserted into an expression vector and transformed into T. subcordiformis chloroplast, followed by in vitro and in vivo functional evaluations of the antimicrobial activities of ALFPm3–2 by minimum inhibitory concentration method and bay scallop breeding experiment, respectively. The results showed that the transformants of T. subcordiformis and the purified ALFPm3–2 had significant inhibitory effects on Vibrio parahaemolyticus and Staphylococcus aureus in vitro , while feeding the transformants reduced the colonization of the two pathogens in bay scallops, which further reduced bay scallops’ mortality by 28.67 % as revealed in infection test. Furthermore, daily oral administration of ALFPm3–2 could improve the gut microbial community and reduce the inflammatory response. Combined with changes in immune factors and endotoxin, it indicated that exogenous ALFPm3–2 played antimicrobial and anti-inflammatory functions in the guts of bay scallops. Overall, this study provided strong evidence to support the oral administration of antimicrobial peptides via microalgae in aquaculture. • Fusion ALFPm3 was expressed in Tetraselmis subcordiformis with enhanced activity but no detrimental effect on growth. • ALFPm3–2 showed strong inhibitory activity against pathogens both in vitro and in the scallop gut. • Oral T. subcordiformis transformant with ALFPm3–2 reduced mortality in scallops. • ALFPm3–2 showed antibacterial and anti-inflammatory activity in the guts of scallop. • ALFPm3–2 improved the gut microbial community of scallops with increasing beneficial bacteria.

Authors

Institutions

Publication Details

Journal
Aquaculture Reports
Published
2024-10-18
DOI
https://doi.org/10.1016/j.aqrep.2024.102430
Primary Topic
Protein Hydrolysis and Bioactive Peptides
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Oral administration of anti-lipopolysaccharide factor isoform 3 via the bait microalga for controlling bacterial infection of Atlantic Bay scallop (Argopecten irradians)

Fengjie Sun, Yan Cheng, Qiaolei Wang, Hao Zhang et al.
Aquaculture Reports
Protein Hydrolysis and Bioactive Peptides
article

Oral administration of anti-lipopolysaccharide factor isoform 3 via the bait microalga for controlling bacterial infection of Atlantic Bay scallop (Argopecten irradians)

Fengjie Sun, Yan Cheng, Qiaolei Wang, Hao Zhang, Ping Liu, Yulin Cui, Yaping Shao, Zhengquan Gao
article en

Abstract

In order to reduce antibiotic application in aquaculture, an antimicrobial peptide anti-lipopolysaccharide factor isoform 3 (ALFPm3) with highly effective inhibitory activity against pathogens was introduced to bay scallop ( Argopecten irradians ) using bait microalga Tetraselmis subcordiformis as a delivery system. To improve its expression and stability, a fusion of two alfpm3 genes ( alfpm3–2 ) was inserted into an expression vector and transformed into T. subcordiformis chloroplast, followed by in vitro and in vivo functional evaluations of the antimicrobial activities of ALFPm3–2 by minimum inhibitory concentration method and bay scallop breeding experiment, respectively. The results showed that the transformants of T. subcordiformis and the purified ALFPm3–2 had significant inhibitory effects on Vibrio parahaemolyticus and Staphylococcus aureus in vitro , while feeding the transformants reduced the colonization of the two pathogens in bay scallops, which further reduced bay scallops’ mortality by 28.67 % as revealed in infection test. Furthermore, daily oral administration of ALFPm3–2 could improve the gut microbial community and reduce the inflammatory response. Combined with changes in immune factors and endotoxin, it indicated that exogenous ALFPm3–2 played antimicrobial and anti-inflammatory functions in the guts of bay scallops. Overall, this study provided strong evidence to support the oral administration of antimicrobial peptides via microalgae in aquaculture. • Fusion ALFPm3 was expressed in Tetraselmis subcordiformis with enhanced activity but no detrimental effect on growth. • ALFPm3–2 showed strong inhibitory activity against pathogens both in vitro and in the scallop gut. • Oral T. subcordiformis transformant with ALFPm3–2 reduced mortality in scallops. • ALFPm3–2 showed antibacterial and anti-inflammatory activity in the guts of scallop. • ALFPm3–2 improved the gut microbial community of scallops with increasing beneficial bacteria.

Aquaculture ReportsVol. 39
Qingdao University (CN), Binzhou Medical University (CN), Shandong University of Aeronautics (CN), Yantai University (CN), Chinese Academy of Sciences (CN), Gwinnett College (US), Yantai Institute of Coastal Zone Research (CN), Shandong Academy of Chinese Medicine (CN), Georgia Gwinnett College (US)
Natural Science Foundation of Shandong Province
Life below water
Openalex Percentile: Top 84%
Protein Hydrolysis and Bioactive Peptides
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.